- Advertisement -
Melbourne-based Telix Pharmaceuticals’ (ASX: TLX) is facing a potential class action lawsuit in the US over allegations that the company misled shareholders regarding the progress it is making with its prostate cancer therapeutic candidates.
California-based Gross Law Firm has reached out to…
Click here to view the original article.
